Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001376474-26-000030·Forte Biosciences, Inc.
Schedule 13G ownership disclosure
Forte Biosciences Inc
Common Stock, $0.001 par value · CUSIP: 34962G208
Event date: 2026-01-08
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Oliveira Steven Michael
Shares: 300,100 · Class: 2.4%
- Nemean Asset Management, LLC
Shares: 300,100 · Class: 2.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001376474-26-000030
- Form type
- SCHEDULE 13G/A
- Filer
- Forte Biosciences, Inc.
- CIK
- CIK 1419041
- Filed
- Jan 09, 2026
- Reporting period
- Jan 08, 2026
- Description
- Schedule 13G beneficial ownership